Dr. Christopher J. Vesy, MD

Dr. Vesy practices at Dallas Endoscopy Center in Dallas, Texas.

Dr. Vesy's NPI, 1033292123, was assigned on October 23, 2006. Dr. Vesy graduated from Ohio State College of Medicine in 1993. Dr. Vesy's Texas license number on file is K3871.

Dr. Vesy's primary practice is Dallas Endoscopy Center, at 3930 Crutcher Street, Dallas, TX 75246. The practice phone is (214) 520-8235.

Dr. Vesy's primary practice is Dallas Endoscopy Center in Dallas, Texas. Dr. Vesy is also affiliated with Baylor University Medical Center. The medical group on file is Texas Digestive Disease Consultants. Dmand AI also links Dr. Vesy to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Vesy practices, 3 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Vesy's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Vesy is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Vesy's licenses on file in 2 states: Texas and North Carolina.

Dmand AI lists acid reflux, chronic inflammatory bowel disease (IBD), cirrhosis of the liver, colonoscopy, gastroenteritis, gastrointestinal bleeding, intestinal diverticulosis and irritable bowel syndrome (IBS) among the conditions Dr. Vesy treats.

CMS data shows 477 Medicare services from Dr. Vesy across 12 procedure codes in 2024, for 300 Medicare patients. Medicare paid $55,761 for them.

CMS counts 300 Medicare patients who saw Dr. Vesy in 2024. The largest group is 65 to 74, with 203 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 0.97, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Vesy's median patient age at 60, with 17% women.

In 2024, Dr. Vesy wrote 1,000 Medicare Part D claims for 416 patients. 82% of them were for generic drugs. CMS names the drug for 825 of them, across 14 drugs with 11 or more claims each, at $99,543 in total drug cost. In 2023, CMS named 849 claims across 18 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Vesy for performance year 2024, reported as part of a group. Dr. Vesy accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 56 procedures of colonoscopy by Dr. Vesy, more than 66% of the clinicians it reports for that procedure.

Dmand AI links 6 papers to Dr. Vesy in 2016. 2016 was the busiest year, with 2. The most frequent topics are Base Sequence, Cytomegalovirus and DNA, Viral.

CMS Open Payments shows 161 general payments to Dr. Vesy from 21 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Takeda Pharmaceuticals U.S.A., Inc. paid the most, $454.

Dmand AI lists 1 award for Dr. Vesy, most recently CMS Stage 1 2012 in 2011.

Dr. Vesy graduated from Ohio State College of Medicine in 1993. Dr. Vesy is a member of ACG, AGA and ASGE.

Dr. Vesy is in network with 21 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.